MNB Pharmaceutical Company is planning to invest EGP 230 mn in a new meds production facility in Borg El Arab, Chairman Mohamed Bazazo said. The first phase of the factory will come online by January 2021, and will be fully commissioned in 2025, according to Bazazo. The company plans to direct most of the factory’s output toward exports.
More from Enterprise
How correspondent banking works, and what the FinCEN clampdown on Banque Misr UAE means for business
As FinCEN proposes cutting Banque Misr’s UAE branches from USD…
Inside the financing of Egypt’s IPP boom
The contracts and the resources are proven, so the open…
EGX30 gained 2.79% in 3Q, but September gave back most of its July-August run, with mid-caps falling the hardest
Small- and mid-cap indices widened their lead over the benchmark…
Egyptian-UK fintech Zeal raises USD 10 mn to back expansion plans
The London-based, Egyptian-founded fintech is preparing to activate its loyalty…